Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-05-27 @ 3:32 AM
Study NCT ID:
NCT01739218
Status:
COMPLETED
Last Update Posted:
2019-08-13
First Post:
2012-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ovarian Cancer | View |
Keywords: